View Full Paper

Pharmacovigilance for Elderly Patients: Cost–Benefit Analysis | A randomized controlled trial design

• MLOps
• CV
• Esports

Abstract

This essay investigates “Pharmacovigilance for Elderly Patients: Cost–Benefit Analysis | A randomized controlled trial design” using a social network analysis. Through a human-centered lens, the analysis integrates multi-source data to derive novel empirical evidence for researchers and practitioners.